Clinical Trials Browser

Cholangiocarcinoma × Immune Checkpoint Inhibitors × 1 year × Clear all

NCT07432568 2026-02-25

A Study of Liposomal Irinotecan Plus 5-FU/LV HAIC With Lenvatinib and a PD-1 Inhibitor in Advanced ICC

Phase 2 Not yet recruiting

Gastrointestinal

Cholangiocarcinoma